Tumor Markers Rapid Tests

Tumor Markers Rapid Tests

Tumor Markers Rapid Tests are advanced in vitro diagnostic (IVD) devices designed for the fast, accurate, and reliable detection of tumor-associated biomarkers in human samples, including whole blood (WB), serum (S), plasma (P), and feces. Leveraging lateral flow immunoassay technology, these tests deliver clear and easy-to-interpret results within minutes, providing essential support for early cancer screening, diagnosis, and ongoing patient monitoring.

These tests are particularly valuable in clinical settings, enabling healthcare professionals to:

• Detect elevated tumor markers associated with cancers such as liver, colorectal, prostate, ovarian, breast, and pancreatic cancers.
• Identify gastrointestinal bleeding or inflammation through fecal occult blood (FOB), hemoglobin, transferrin, or calprotectin detection.
• Make timely, evidence-based decisions for patient management and treatment planning.

With their user-friendly design, minimal equipment requirements, and rapid turnaround, Tumor Markers Rapid Tests are suitable for use in hospitals, clinical laboratories, screening centers, and even at-home self-testing for select kits. By providing reliable results quickly, these tests contribute to early intervention, improved patient outcomes, and more efficient healthcare workflows.